Sodium salicylate activates caspases and induces apoptosis of myeloid leukemia cell lines

Blood

Volumn 93, Issue 7, 1999, Pages 2386-2394

  Klampfer, Lidija ^b   Cammenga, Jörg ^b   Wisniewski, Hans Georg ^b   Nimer, Stephen D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DAUNORUBICIN; GELSOLIN; GROWTH FACTOR; LIPOCORTIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; SALICYLATE SODIUM;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER PREVENTION; COLON CANCER; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LUNG CANCER; MYELOID LEUKEMIA; PRIORITY JOURNAL;

EID: 0033121186     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.7.2386     Document Type: Article

References (60)

1. Morgan G: Non-steroidal anti-inflammatory drugs and the chemoprevention of colorectal and oesophageal cancers. Gut 38:646, 1996
2. Peleg II, Lubin MF, Cotsonis GA, Clark WS, Wilcox CM: Long-term use of nonsteroidal antiinflammatory drugs and other chemopreventors and risk of subsequent colorectal neoplasia. Dig Dis Sci 41:1319, 1996
3. Sandler RS: Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer, in DeVita VT, Hellman S, Rosenberg S (eds): Important Advances in Oncology. Philadelphia, PA, Lippincott-Raven, 1996, p 123
4. Vainio H, Morgan G, Kleihues P: An international evaluation of the cancer-preventive potential of nonsteroidal anti-inflammatory drugs. Cancer Epidemiol Biomarkers Prev 6:749, 1997
5. Smalley WE, DuBois RN: Colorectal cancer and nonsteroidal anti-inflammatory drugs. Adv Pharmacol 39:1, 1997
6. Shiff SJ, Qiao L, Tsai LL, Rigas B: Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest 96:491, 1995
7. Bunce CM, Mountford JC, French PJ, Mole DJ, Durham J, Michell RH, Brown G: Potentiation of myeloid differentiation by anti-inflammatory agents, by steroids and by retinoic acid involves a single intracellular target, probably an enzyme of the aldoketoreductase family. Biochim Biophys Acta 1311:189, 1996
8. Shiff SJ, Koutsos MI, Qiao L, Rigas B: Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: Effects on cell cycle and apoptosis. Exp Cell Res 222:179, 1996
9. Bailly JD, Skladanowski A, Bettaieb A, Mansat V, Larsen AK, Laurent G: Natural resistance of acute myeloid leukemia cell lines to mitoxantrone is associated with lack of apoptosis. Leukemia 11:1523, 1997
10. Glinsky GV: Apoptosis in metastatic cancer cells. Crit Rev Oncol Hematol 25:175, 1997
11. Hannun YA: Apoptosis and the dilemma of cancer chemotherapy. Blood 89:1845, 1997
12. Schwenger P, Bellosta P, Victor I, Basilico C, Skolnik EY, Vilcek J: Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. Proc Natl Acad Sci USA 94:2869, 1997
13. Schwenger P, Skolnik EY, Vilcek J: Inhibition of tumor necrosis factor-induced p42/p44 mitogen-activated protein kinase activation by sodium salicylate. J Biol Chem 271:8089, 1996
14. Huang C, Ma WY, Hanenberger D, Cleary MP, Bowden GT, Dong Z: Inhibition of ultraviolet B-induced activator protein-1 (AP-1) activity by aspirin in AP-1-luciferase transgenic mice. J Biol Chem 272:26325, 1997
15. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326, 1995
16. Kopp E, Ghosh S: Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265:956, 1994
17. Mayo MW, Wang CY, Cogswell PC, Rogers-Graham KS, Lowe SW, Der CJ, Baldwin A Jr: Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 278:1812, 1997
18. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM: Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274:787, 1996
19. Wang CY, Mayo MW, Baldwin A Jr: TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-kappaB. Science 274:784, 1996
20. Beg AA, Baltimore D: An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274:782, 1996
21. Dong Z, Huang C, Brown RE, Ma WY: Inhibition of activator protein 1 activity and neoplastic transformation by aspirin. J Biol Chem 272:9962, 1997
22. Goedert M, Cuenda A, Craxton M, Jakes R, Cohen P: Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6): Comparison of its substrate specificity with that of other SAP kinases. EMBO J 16:3563, 1997
23. Chao JR, Wang JM, Lee SF, Peng HW, Lin YH, Chou CH, Li JC, Huang HM, Chou CK, Kuo ML, Yen JJY, Yang-Yen HF: mcl-1 is an immediate-early gene activated by the granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling pathway and is one component of the GM-CSF viability response. Mol Cell Biol 18:4883, 1998
24. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C: A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184:39, 1995
25. Kinoshita T, Yokota T, Arai K, Miyajima A: Suppression of apoptotic death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors. EMBO J 14:266, 1995
26. Boise LH, Gottschalk AR, Quintans J, Thompson CB: Bcl-2 and Bcl-2-related proteins in apoptosis regulation. Curr Top Microbiol Immunol 200:107, 1995
27. Nicholson DW, Thornberry NA: Caspases: Killer proteases. Trends Biochem Sci 22:299, 1997
28. Salvesen GS, Dixit VM: Caspases: Intracellular signaling by proteolysis. Cell 91:443, 1997
29. Ibrado AM, Huang Y, Fang G, Liu L, Bhalla K: Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. Cancer Res 56:4743, 1996
30. Ohta T, Kinoshita T, Naito M, Nozaki T, Masutani M, Tsuruo T, Miyajima A: Requirement of the caspase-3/CPP32 protease cascade for apoptotic death following cytokine deprivation in hematopoietic cells. J Biol Chem 272:23111, 1997
31. Schlegel J, Peters I, Orrenius S, Miller DK, Thornberry NA, Yamin TT, Nicholson DW: CPP32/apopain is a key interleukin 1 beta converting enzyme-like protease involved in Fas-mediated apoptosis. J Biol Chem 271:1841, 1996
32. Piedrafita FJ, Pfahl M: Retinoid-induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activation. Mol Cell Biol 17:6348, 1997
33. Mashima T, Naito M, Noguchi K, Miller DK, Nicholson DW, Tsuruo T: Actin cleavage by CPP-32/apopain during the development of apoptosis. Oncogene 14:1007, 1997
34. Martin SJ, O'Brien GA, Nishioka WK, McGahon AJ, Mahboubi A, Saido TC, Green DR: Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J Biol Chem 270:6425, 1995
35. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC: Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371:346, 1994
36. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ, Kirschner MW, Koths K, Kwiatkowski DJ, Williams LT: Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis. Science 278:294, 1997
37. Weissmann G: Aspirin. Sci Am 264:84, 1991
38. Insel PA: Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout, in Hardman JG, Gilman AG, Limbird LE (eds): The Pharmacological Basis of Therapeutics (ed 9). New York, NY, McGraw-Hill, 1996, p 617
39. Meredith TJ, Vale JA: Therapeutic Applications of NSAID. Subpopulations and New Formulations. New York, NY, Dekker, 1992
40. Sanchez-Garcia I, Grutz G: Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2. Proc Natl Acad Sci USA 92:5287, 1995
41. Reynolds JE, Yang T, Qian L, Jenkinson JD, Zhou P, Eastman A, Craig RW: Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. Cancer Res 54:6348, 1994
42. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479, 1997
43. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG: Specific proteolytic cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Res 53:3976, 1993
44. Wang ZQ, Stingl L, Morrison C, Jantsch M, Los M, Schulze-Osthoff K, Wagner EF: PARP is important for genomic stability but dispensable in apoptosis. Genes Dev 11:2347, 1997
45. Asch HL, Head K, Dong Y, Natoli F, Winston JS, Connolly JL, Asch BB: Widespread loss of gelsolin in breast cancers of humans, mice, and rats. Cancer Res 56:4841, 1996
46. Tanaka M, Mullauer L, Ogiso Y, Fujita H, Moriya S, Furuuchi K, Harabayashi T, Shinohara N, Koyanagi T, Kuzumaki N: Gelsolin: A candidate for suppressor of human bladder cancer. Cancer Res 55:3228, 1995
47. Mesner P Jr, Budihardjo II, Kaufmann SH: Chemotherapy-induced apoptosis. Adv Pharmacol 41:461, 1997
48. Johnston JB, Daeninck P, Verburg L, Lee K, Williams G, Israels LG, Mowat MR, Begleiter A: P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia. Lymphoma 26:435, 1997
49. Wilson WH, Teruya-Feldstein J, Fest T, Harris C, Steinberg SM, Jaffe ES, Raffeld M: Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas. Blood 89:601, 1997
50. Minn AJ, Rudin CM, Boise LH, Thompson CB: Expression of bcl-xL can confer a multidrug resistance phenotype. Blood 86:1903, 1995
51. Zhou P, Qian L, Kozopas KM, Craig RW: Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions. Blood 89:630, 1997
52. Kaufmann SH, Karp JE, Svingen PA, Krajewski S, Burke PJ, Gore SD, Reed JC: Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse. Blood 91:991, 1998
53. Jansen B, Schlagbauer-Wadl H, Brown BD, Bryan RN, van Elsas A, Muller M, Wolff K, Eichler HG, Pehamberger H: BCl-2 antisense therapy chemosensitizes human melanoma in SCID mice. Nature Med 4:232, 1998
54. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R: Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals. Cell 82:405, 1995
55. Smyth MJ, Perry DK, Zhang J, Poirier GG, Hannun YA, Obeid LM: prICE: A downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2. Biochem J 316:25, 1996
56. Boland MP, Foster SJ, O'Neill LA: Daunorubicin activates NFkappaB and induces kappaB-dependent gene expression in HL-60 promyelocytic and Jurkat T lymphoma cells. J Biol Chem 272:12952, 1997
57. Jeremias I, Kupatt C, Baumann B, Herr I, Wirth T, Debatin KM: Inhibition of nuclear factor kappaB activation attenuates apoptosis resistance in lymphoid cells. Blood 91:4624, 1998
58. Zhan Q, Bieszczad CK, Bae I, Fornace AJ Jr, Craig RW: Induction of BCL2 family member MCL1 as an early response to DNA damage. Oncogene 14:1031, 1997
59. Yang T, Buchan HL, Townsend KJ, Craig RW: MCL-1, a member of the BLC-2 family, is induced rapidly in response to signals for cell differentiation or death, but not to signals for cell proliferation. J Cell Physiol 166:523, 1996
60. Bellosillo B, Piqué M, Barragán M, Castaño E, Villamor N, Colomer D, Montserrat E, Pons G, Gil J: Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood 92:1406, 1998